Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy
{{output}}
Background: Choriocarcinoma is a highly aggressive gestational trophoblastic neoplasm. Patients with ultra-high-risk disease (FIGO score ≥ 13) and brain metastases face cure rates of only 50-80% and require intensive multimodal therapy. Case: We present the c... ...
